Exceptional Response of BRAFV600E-Mutated Acinar Cell CUP to BRAF/MEK Inhibition
Research output: Contribution to journal › Research article › Contributed
Contributors
Abstract
Complete remission of BRAF V600E-driven ACC CUP by BRAF/MEK inhibition underscores importance of precision oncology.
Details
| Original language | English |
|---|---|
| Pages (from-to) | e2400030 |
| Journal | JCO precision oncology |
| Volume | 8 |
| Issue number | 8 |
| Publication status | Published - May 2024 |
| Peer-reviewed | No |
External IDs
| Mendeley | 138e238f-0d9a-357b-aaf1-6af2a3aaec97 |
|---|
Keywords
Keywords
- Proto-Oncogene Proteins B-raf/genetics, Humans, Protein Kinase Inhibitors/therapeutic use, Mutation, Male, Female, Middle Aged, Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors